Risk factors for hepatitis C virus acquisition and predictors of persistence among Egyptian children

Liver International

Volumn 32, Issue 3, 2012, Pages 449-456

  Esmat, Gamal ^a   Hashem, Mohamed ^b   El Raziky, Mona ^a   El Akel, Wafaa ^a   El Naghy, Suzan ^c   El Koofy, Nehal ^a   El Sayed, Rokaya ^a   Ahmed, Rasha ^a   Atta Allah, Mohamed ^c   Hamid, Mohamed Abdel ^c,d   El Kamary, Samer S ^b   El Karaksy, Hanaa ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c NATIONAL HEPATOLOGY AND TROPICAL MEDICINE RESEARCH INSTITUTE   (Egypt)

^d MINIA UNIVERSITY   (Egypt)

Author keywords

Children; Egypt; HCV; Persistent HCV infection; Spontaneous clearance of HCV

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS C ANTIBODY; VIRUS RNA;

ARTICLE; BLOOD TRANSFUSION; CHILD; COMORBIDITY; DENTAL PROCEDURE; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRESCHOOL CHILD; SCHOOL CHILD; SEX DIFFERENCE; VIRAL CLEARANCE;

AGE FACTORS; CHILD; CHILD, PRESCHOOL; EGYPT; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; INFANT; LOGISTIC MODELS; MALE; PREVALENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES;

EID: 84856636296     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2011.02643.x     Document Type: Article

References (47)

1. Frank C, Mohamed MK, Strickland GT, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000; 355: 887-91.
2. Strickland GT. Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors. Hepatology 2006; 43: 915-22.
3. El-Zanaty F, Way A. Egypt Demographic and Health Survey 2008. Cairo: Egypt: Ministry of Health (El-Zanaty and Associates and Macro International), 2009; p. 431.
4. Aziz F, Habib M, Mohamed MK, et al. Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence. Hepatology 2000; 32: 111-5.
5. Habib M, Mohamed MK, Abdel-Aziz F, et al. Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity. Hepatology 2001; 33: 248-53.
6. Medhat A, Shehata M, Magder LS, et al. Hepatitis C in a community in Upper Egypt: risk factors for infection. Am J Trop Med Hyg 2002; 66: 633-8.
7. Nafeh MA, Medhat A, Shehata M, et al. Hepatitis C in a community in Upper Egypt: I. Cross-sectional survey: Am J Trop Med Hyg 2000; 63: 236-41.
8. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002; 36 (5 Suppl. 1): S35-46.
9. Thomas DL, Astemborski J, Rai RM, et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 2000; 284: 450-6.
10. Rodger AJ, Roberts S, Lanigan A, et al. Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975. Hepatology 2000; 32: 582-7.
11. Villano SA, Vlahov D, Nelson KE, et al. Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology 1999; 29: 908-14.
12. El-Nanawy AA, El Azzouni OF, Soliman AT, et al. Prevalence of hepatitis-C antibody seropositivity in healthy Egyptian children and four high risk groups. J Trop Pediatr 1995; 41: 341-3.
13. Said ZN, El-Sayed MH, El-Bishbishi IA, et al. High prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies. Liver Int 2009; 29: 518-24.
14. El-Raziky MS, El-Hawary M, El-Koofy N, et al. Hepatitis C virus infection in Egyptian. J Viral Hepat 2004; 11: 471-6.
15. Paez Jimenez A, Sharaf Eldin N, Rimlinger F, et al. HCV iatrogenic and intrafamilial transmission in Greater Cairo, Egypt. Gut 2010; 59: 1554-60.
16. Saleh DA, Shebl FM, El-Kamary SS, et al. Incidence and risk factors for community-acquired hepatitis C infection from birth to 5 years of age in rural Egyptian children. Trans R Soc Trop Med Hyg 2010; 104: 357-363.
17. Talaat M, Kandeel A, Rasslan O, et al. Evolution of infection control in Egypt: achievements and challenges Evolution of infection control in Egypt: achievements and challenges. Am J Infect Control 2006 May; 34: 193-200.
18. Talaat M, Afifi S, Dueger E, El-Ashry N, et al. Effects of Hand hygiene campaigns on incidence of laboratory-confirmed Influenza and absenteeism in schoolchildren, Cairo, Egypt. EID 2011;17: 619-25.
19. The European Paediatric Hepatitis C Network. Three Broad Modalities in the Natural History of Vertically Aquired Hepatitis C Infection. CID 2005;41: 45-51.
20. Abdel-Hamid M, El-Daly M, El-Kafrawy S, et al. Comparison of second- and third-generation enzyme immunoassays for detecting antibodies to hepatitis C virus. J Clin Microbiol 2002; 40: 1656-9.
21. Abdel-Hamid M, Edelman DC, Highsmith WE, et al. Optimization, assessment, and proposed use of a direct nested reverse transcription-polymerase chain reaction protocol for the detection of hepatitis C virus. J Hum Virol 1997; 1: 58-65.
22. Kelly D, Skidmore S. Hepatitis C-Z: recent advances. Arch Dis Child 2002; 86: 339-43.
23. Zein NN. Hepatitis C in children: recent advances. Curr Opin Pediatr 2007; 19: 570-4.
24. Jafri W, Jafri N, Yakoob J, et al. Hepatitis B and C: prevalence and risk factors associated with seropositivity among children in Karachi, Pakistan. BMC Infect Dis 2006; 23: 101.
25. Waheed Y, Shafi T, Safi SZ, et al. Hepatitis C virus in Pakistan: a systematic review of prevalence, genotypes and risk factors. World J Gastroenterol 2009; 15: 5647-53.
26. Kamili S, Krawczynski K, McCaustland K, et al. Infectivity of hepatitis C virus in plasma after drying and storing at room temperature. Infect Control Hosp Epidemiol 2007; 28: 519-24.
27. Egyptian Medical Syndicate. Cleaning, disinfection, and sterilization of medical equipment 2008. Available at Accessed 23 April 2011.
28. Madwar MA, El-Gindy I, Fahmy HM, et al. Hepatitis C virus transmission in family members of Egyptian patients with HCV related chronic liver disease. J Egypt Public Health Assoc 1999;74: 313-32.
29. El-Raziky MS, El-Hawary M, Esmat G, et al. Prevalence and risk factors of asymptomatic hepatitis C virus infection in Egyptian children. World J Gastroenterol 2007; 13: 1828-32.
30. Shebl FM, El-Kamary SS, Saleh DA, et al. Prospective cohort study of mother-to-infant infection and clearance of hepatitis C in rural Egyptian villages J. Med. Virol 2009; 81: 1024-31.
31. Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin: Irish Hepatology Research Group. N Engl J Med 1999; 340: 1228-33.
32. Hoofnagle JH. Therapy for acute hepatitis C. NEJM 2001; 345: 1495-7.
33. Rerksuppaphol S, Hardikar W, Dore GJ. Long-term outcome of vertically acquired and post-transfusion hepatitis C infection in children. J Gastroenterol Hepatol 2004; 19: 1357-62.
34. Yeung LT, To T, King SM, et al. Spontaneous clearance of childhood hepatitis C virus infection. J Viral Hepat 2007; 14: 797-805.
35. Pirisi M, Toniutto P, Fabris C, et al. Factors associated with serum HCV RNA positivity in anti-HCV antibody positive intravenous drug users. J Clin Epidemiol 1998; 51: 423-7.
36. Posthouwer D, Fischer K, van Erpecum KJ, et al. The natural history of childhood-acquired hepatitis C infection in patients with inherited bleeding disorders. Transfusion 2006; 46: 1360-6.
37. Vogt M, Lang T, Frösner G, et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med 1999; 341: 866-70.
38. Jara P, Resti M, Hierro L, et al. Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children. Clin Infect Dis 2003; 36: 275-80.
39. Bortolotti F, Verucchi G, Cammà C, et al. Italian Observatory for HCV infection and hepatitis C in children. Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. Gastroenterology 2008; 134: 1900-7.
40. Ray SC, Arthur RR, Carella A, et al. Genetic epidemiology of hepatitis C virus throughout Egypt. J Infect Dis 2000; 182: 698-707.
41. Tanaka Y, Agha S, Saudy N, et al. Genetic epidemiology of hepatitis C virus throughout Egypt. Exponential spread of hepatitis C virus genotype 4a in Egypt. J Mol Evol 2004; 58: 191-5.
42. Simmonds P, McOmish F, Yap PL, et al. Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol. 1993; 74 (Pt 4): 661-8.
43. Gerlach JT, Diepolder HM, Jung MC, et al. Recurrence of hepatitis C virus after loss of virus-specific CD4 (+) T-cell response in acute hepatitis C. Gastroenterology 1999; 117: 933-941.
44. Gerlach JT, Diepolder HM, Zachoval R, et al. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 2003; 125: 80-88.
45. Micallef JM, Kaldor JM, Dore GJ. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat 2006; 13: 34-41.
46. Jauncey M. Clearance of hepatitis C virus after newly acquired infection in injection drug users. J Infect Dis 2004; 190: 1270-4.
47. Thomas DL, Thio CL, Martin ML, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009; 461: 798-801.